Trade Summary

5 days ago, Hoffman Michael B, serving as Dir at Annovis Bio, Inc. (ANVS), purchased 76,344 shares at $1.87 per share, for a total transaction value of $142,779.00. Following this transaction, Hoffman Michael B now holds 3,588,240 shares of ANVS.

This purchase represents a 2.00% increase in Hoffman Michael B's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 20, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 21, 2026 at 8:11 PM ET, 1 day after the trade was made.

Annovis Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.